Literature DB >> 9456021

Soluble CD23 levels and their correlation with erythrocyte sedimentation rate and with copy number of Epstein-Barr virus genome in rheumatoid arthritis patients.

S Sawada, K Mitamura, M Takei, T Okubo, S Fujiwara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9456021     DOI: 10.1007/bf02247809

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients.

Authors:  O M Martinez; J C Villanueva; L Lawrence-Miyasaki; M B Quinn; R Gish; K Cox; S So; C O Esquivel; S M Krams
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 2.  Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis.

Authors:  J M Depper; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1981-06

3.  [Severe chronic Epstein-Barr virus infection with natural killer cell defect].

Authors:  K Hartung; S Le Blanc; A Franz; R Jacobs; C Wittekind; G W Bornkamm; R E Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1988-12-16       Impact factor: 0.628

4.  Formation of IgE-binding factors by T cells of patients infected with human immunodeficiency virus type 1.

Authors:  C Carini; J Margolick; J Yodoi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.

Authors:  P Chomarat; J Briolay; J Banchereau; P Miossec
Journal:  Arthritis Rheum       Date:  1993-02

6.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

Authors:  L Slaughter; D A Carson; F C Jensen; T L Holbrook; J H Vaughan
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.